Revision as of 00:05, 22 October 2019

Team

Team Members Collaborations

Project

Description Design Experiments Notebook Contribution Results Demonstrate Improve Attributions

Parts

Parts Overview Basic Parts Composite Parts

Safety

Human Practices

Human Practices Education & Public Outreach

Judging Form Team Impact Contact Us

Results

This page represents our highlighted and core experiments that allowed iGEM Guelph to produce our AmilCP and Violacein Biosensors. This is not an exhaustive list or presentation of the work done. For any further clarification, please refer to our lab notebook as all of our experiments are catalogued there. In order to create our biosensor, we began by setting out to determine whether the common lab Escherichia coli strains - DH5α and BL21(DE3) - would be able to survive high enough concentrations of tetracycline to be useful as a biosensor. This was done by performing minimum inhibitory concentration (MIC) assays in a 96-well plate. We also mapped a growth curve of both strains in the presence of tetracycline in order to see what quantities of the drug inhibited growth.

Initial Work with E. coli in Tetracycline

To test the tolerance of E. coli to tetracycline, DH5α and BL21 (DE3) strains were grown in a 96-well plate, each in 200 μL of LB, in serially diluted tetracycline from 40 μg/mL to 0.04 ng/mL. The plates were shaken at 900 rpm at 37 °C, and the optical density at 600nm was recorded after 24hours using the Tecan Infinite Series Pro 200 96-well plate reader.

When the ODs were normalized to the no drug control, we were able to calculate our MIC₅₀, which is the value of where the growth of the cells are inhibited by 50%. We saw that our MIC₅₀ was at 312.5ng/mL as described where the normalized OD values fell below 0.5. This means that half of the cells from both strains were able to survive in up to 312.5 ng/mL tetracycline compared to cells growing in wells without tetracycline. This was great news as 312.5ng/mL is slightly more than three times the regulatory limit for tetracycline in dairy products in Canada (100 ng/mL). With this information, we felt confident that both DH5α and BL21 (DE3) strains would survive above the regulatory limit and will be used for the development and initial testing of our tetracycline biosensor.

Now that we know our strains were fine, we ordered the plasmid pJKR-H-TetR (p-Tet) from addgene that is the backbone on which we based our tet-O DNA synthesis¹. We then needed to test the rate of growth of our strains in ampicillin and tetracycline as ampicillin will be needed to maintain the plasmid. We transformed our pTet plasmid that contained ampicillin resistance into our DH5α strain. We then created growth curves by growing E. coli in LB broth at 37°C shaking at 250 rpm overnight. The cultures were then diluted 1:1000 in 50 mL LB media. Based on the paper we obtained p-Tet from, the highest dose of tetracycline the researchers used was 267ng/mL. We wanted this experiment to quantify the impact that tetracycline would have on growth and capture the start of log phase for these cells. In our future work, we will be using lower volumes of tetracycline; So we wanted to capture growth in the highest concentration of tetracycline (and therefore the longest lag phase). So for this experiment we added tetracycline to a final concentration of 267 ng/mL and ampicillin to a final concentration of 100 μg/mL. For our negative control, we diluted the cultures into flasks that contained 100 μg/mL of Amp, without any tetracycline. The flasks were incubated shaking at 250 rpm in 37°C for 14 hours, taking absorbance readings at 600 nm every 2 hours.

From the analysis of our growth curves, we were able to determine that E. coli in tetracycline begins log phase after 4h of growth. Our control strain had almost no lag phase and started logarithmic growth almost immediately. This means that after 4 hours, with the highest concentration of tetracycline that we would use to induced expression of our pigments, we should clearly see colour being produced. We anticipate based on these results that the longest time is should take the cells to reach log phase would be 4 hours and with lower concentrations of tetracycline, it should take even less time. This information was used when determining when to harvest cells for expression testing.

Validating the Responsiveness of BBa_K3189001 to Tetracycline

The next step was to determine the sensitivity of our new biobrick, BBa_K3189001, a tetracycline-activated phage lambda promoter. To do this, DH5α and BL21(DE3) cells containing the pTet plasmid were grown in 50 mL LB media containing tetracycline to a final concentration of 50 ng/mL, as well as 100 μg/mL ampicillin to maintain the plasmid. We chose 50 ng/mL as it was under the regulatory limit and we wanted to push the limits of our test so we also measured 1ng/mL which previously showed no additional fluorescence beyond background levels (data not shown). The flasks were incubated and shaken at 37°C at 250 rpm for 6 hours. The 6 hour time point was chosen based on the point where we were confident that the cells were past log phase from our previous growth curve experiments. After six hours, the cells grown in flasks were washed and resuspended in PBS to reduce the autofluorescence by LB media. When assessed under UV light, it was clear that the 50 ng/mL of tetracycline showed a visible increase in fluorescence compared to the same cells grown in only 1 ng/mL tetracycline (Figure 3).

Since GFP was visibly produced with tetracycline present at only 50 ng/mL, half the maximum concentration of tetracycline allowed in dairy products in Canada, we concluded that BBa_K3189001 is sensitive enough to tetracycline to be useful in our biosensor.

E. coli BL21 and DH5α cells containing pTet were also grown in a 96-well plate with a decreasing gradient of tetracycline in the same manner as a MIC plate. We did this attempting to establish a linear relationship between concentration of tetracycline and fluorescence by growing pTet containing BL21(DE3) and DH5α cells in sequentially diluted concentrations of tetracycline in a 96-well plate. Unfortunately, we had difficulties with our Tecan Infinite Pro200 plate reader measuring fluorescence, so we were not able to establish a quantitative relationship between the two variables. However, we were able to visualize the 96-well plate under UV light to qualitatively assess this relationship (Figure 4).

What we observed was that as expected, fluorescence generally increased with higher tetracycline concentrations. The brightest fluorescence was seen at 312.5 ng/mL highlighted in red. This was interesting as this is the same value that is the determined MIC₅₀ of E. coli in tetracycline) This may be due to tetracycline affecting the cell’s metabolism and above their MIC50 that they grow so poorly or no longer have a functioning metabolism that allows them to adequately respond to the tetracycline by producing GFP.

Improvement of BBa_K1343022: Addition of BBa_K3189001

To create a biosensor we first wanted to create a basic sense and respond gene circuit that would produce a visible colour change in response to tetracycline. We needed a basic reporter gene and decided to use the chromoprotein AmilCP. We initially wanted to do work with BBa_K592009, the BioBrick that’s from iGEM Uppsala 2011 that has been well characterized. We placed BBa_K1343022, the Amil chromoprotein gene (amilCP), downstream of the BBa_K3189001 tetracycline-responsive promoter. Initially, we attempted to transform the part in pSB1C3 as found in the distribution kit into E. coli DH5α, but no colonies grew on the LB+chloramphenicol plates. The amilCP part of the BBa_K1343022 composite part, including a ribosome binding site immediately upstream (position 84-820) was then amplified by PCR, it and pTet were both digested with EcoRI and PacI restriction enzymes according to our protocol listed, and the AmilCP amplicon was ligated into pTet in the place of GFP.

The identity of the newly created BioBrick, BBa_K3189015, was confirmed by transforming it into E. coli DH5α, selecting colonies that grew on LB+Ampicillin and performing colony PCR, and running gel electrophoresis on the PCR samples.

To see whether the new biosensor was functional, we grew up the cells in 50 mL LB flasks with 50 ng/mL tetracycline (as described above with GFP and in Experiments). After 6h of growth, the cells were washed with PBS and no blue colour was observed.

To see why our part was not working, we sequenced BBa_K3189015 using Sanger sequencing. What we found was a premature stop codon introduced at Gly 129.
The sequences can be found here and href="https://static.igem.org/mediawiki/2019/2/24/T--Guelph--pTA1TetoSeqF1H02.txtt">here

These findings lend support to what has already characterized about BBa_K592009 by iGEM Uppsala in 2018. They have observed that the amilCP protein is mildly toxic to bacteria, and thus there is selective pressure on the host for the gene to mutate and become nonfunctional.

After several failed expression tests with our first version of BBa_K3189015 (based on BBa_K1343022) from iGEM plate we tried to circumvent the problem by synthesizing the sequence found in the registry from IDT. We repeated the same work in order to recreate BBa_K3189015, and this was sent for Sanger sequencing which returned the correct sequence.

We got the sequence into E. coli and did initial expression testing

An expression assay was conducted on the newly remade gene constructs, growing E. coli BBa_K3189015 transformants in a 96-well plate in varying concentrations of tetracycline labeled in Figure 9. The plate was left at 16 °C for one day, and then moved to 4 °C. After two days, pigments were visible, but they intensified after one week at 4°C. A dark blue pigment was seen at 100 ng/mL tetracycline, with less colour visible at 50 ng/mL for some of the samples, and no colour visible in the absence of tetracycline.

Based on the results in Figure 9, it would appear that our biosensor is sensitive enough to distinguish between 50 ng/mL and 100 ng/mL tetracycline, which is useful for seeing if a dairy sample is above the Canadian regulatory limit of 100 ng/mL. However, further work will have to be done in order to create a standard curve relating the intensity of the pigment produced to the concentration of substrate, including normalizing to the number of cells present at the time of sampling.

Characterizing the Expression of BBa_K1349002 at Different Temperatures

Given the instability of BBa_K1343022, the source of amilCP in BBa_K3189015, we also used BBa_K1349002 - a version of amilCP codon optimized for expression in E. coli by iGEM Uppsala in 2018 - to combine with the BBa_K3189001 promoter and create a tetracycline biosensor with E. coli optimized AmilCP, submitted to the registry as BBa_K3189014, using the same molecular cloning procedures as for BBa_K3189015 as outlined in the Experiments section of our Wiki. The identity of the part was confirmed by Sanger sequencing. We used this construction in the characterization of the expression of BBa_K1349002 at different temperatures.

Transformants were grown on LB plates containing 50 ng/mL tetracycline, and the plates were placed at 25 °C and 37 °C overnight. The next day, the colonies grown at 25 °C were a dark colour, while the colonies grown at 37 °C were visibly less pigmented.

From these results it appears that 24 hours at 25°C produced a stronger visual colour change when compared to colonies grown at 37°C for the same amount of time. This is most likely a result of reduced expression or stability of AmilCP at higher temperatures. This seemingly thermal instability makes sense given the fact that this gene was originally form coral which grows at lower temperatures in the ocean.

Validation of Violacein Biosensor: BBa_K3189005

Next: Demonstrate